These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11579300)

  • 21. Factors affecting the pharmacokinetics of tacrolimus (FK506) in hematopoietic cell transplant (HCT) patients.
    Jacobson P; Ng J; Ratanatharathorn V; Uberti J; Brundage RC
    Bone Marrow Transplant; 2001 Oct; 28(8):753-8. PubMed ID: 11781626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tacrolimus pharmacokinetics in the early post-liver transplantation period and clinical applicability via Bayesian prediction.
    Oteo I; Lukas JC; Leal N; Suarez E; Valdivieso A; Gastaca M; Ortiz de Urbina J; Calvo R
    Eur J Clin Pharmacol; 2013 Jan; 69(1):65-74. PubMed ID: 22660442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tacrolimus dose individualization in "de novo" patients after 10 years of experience in liver transplantation: pharmacokinetic considerations and patient pathophysiology.
    Valdivieso N; Oteo I; Valdivieso A; Lukas JC; Leal N; Gastaca M; de Urbina JO; Calvo R; Suarez E
    Int J Clin Pharmacol Ther; 2013 Jul; 51(7):606-14. PubMed ID: 23735178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population pharmacokinetics and pharmacogenetics of tacrolimus in de novo pediatric kidney transplant recipients.
    Zhao W; Elie V; Roussey G; Brochard K; Niaudet P; Leroy V; Loirat C; Cochat P; Cloarec S; André JL; Garaix F; Bensman A; Fakhoury M; Jacqz-Aigrain E
    Clin Pharmacol Ther; 2009 Dec; 86(6):609-18. PubMed ID: 19865079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Population Pharmacokinetic Model to Predict the Individual Starting Dose of Tacrolimus Following Pediatric Renal Transplantation.
    Andrews LM; Hesselink DA; van Gelder T; Koch BCP; Cornelissen EAM; Brüggemann RJM; van Schaik RHN; de Wildt SN; Cransberg K; de Winter BCM
    Clin Pharmacokinet; 2018 Apr; 57(4):475-489. PubMed ID: 28681225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bayesian forecasting and prediction of tacrolimus concentrations in pediatric liver and adult renal transplant recipients.
    Willis C; Staatz CE; Tett SE
    Ther Drug Monit; 2003 Apr; 25(2):158-66. PubMed ID: 12657909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of body composition on pharmacokinetics of tacrolimus in liver transplantation recipients.
    Chen L; Lu X; Tan G; Zhu L; Liu Y; Li M
    Xenobiotica; 2020 Feb; 50(2):186-191. PubMed ID: 30995884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of Factors Affecting Tacrolimus Trough Levels in Latin American Pediatric Liver Transplant Patients.
    Riva N; Woillard JB; Distefano M; Moragas M; Dip M; Halac E; Cáceres Guido P; Licciardone N; Mangano A; Bosaleh A; de Davila MT; Schaiquevich P; Imventarza O
    Liver Transpl; 2019 Sep; 25(9):1397-1407. PubMed ID: 31102573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and validation of individualized tacrolimus dosing software for Chinese pediatric liver transplantation patients: a population pharmacokinetic approach.
    Yang S; Wei J; Pan X; Li Z; Zhang X; Li Z; Dong X; Hua Z; Li X
    Eur J Clin Pharmacol; 2024 Sep; 80(9):1409-1420. PubMed ID: 38904798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Population pharmacokinetic analysis of tacrolimus in Chinese cardiac transplant recipients.
    Gong Y; Yang M; Sun Y; Li J; Lu Y; Li X
    Eur J Hosp Pharm; 2020 Mar; 27(e1):e12-e18. PubMed ID: 32296499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Population pharmacokinetic study of tacrolimus in patients with hematopoietic stem cell transplant].
    Xue L; Rui JZ; Zhang Y; Miao LY
    Yao Xue Xue Bao; 2009 Oct; 44(10):1145-51. PubMed ID: 20055140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population pharmacokinetics of tacrolimus in pediatric hematopoietic stem cell transplant recipients: new initial dosage suggestions and a model-based dosage adjustment tool.
    Wallin JE; Friberg LE; Fasth A; Staatz CE
    Ther Drug Monit; 2009 Aug; 31(4):457-66. PubMed ID: 19531982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Limited sampling strategies for monitoring tacrolimus in pediatric liver transplant recipients.
    Delaloye JR; Kassir N; Lapeyraque AL; Alvarez F; Lallier M; Beaunoyer M; Labbé L; Théorêt Y; Litalien C
    Ther Drug Monit; 2011 Aug; 33(4):380-6. PubMed ID: 21743386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population pharmacokinetic analysis of tacrolimus early after pediatric liver transplantation.
    Musuamba FT; Guy-Viterbo V; Reding R; Verbeeck RK; Wallemacq P
    Ther Drug Monit; 2014 Feb; 36(1):54-61. PubMed ID: 24081207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Pilot Study of the Pharmacokinetics of the Modified-Release Once-Daily Tacrolimus Formulation Administered to Living-Donor Liver Transplant Recipients.
    Song GW; Lee SG; Hwang S; Kim KH; Kim WJ; Sin MH; Yoon YI; Tak EY
    Exp Clin Transplant; 2016 Aug; 14(4):412-8. PubMed ID: 26976646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population pharmacokinetic analysis of tacrolimus in Mexican paediatric renal transplant patients: role of CYP3A5 genotype and formulation.
    Jacobo-Cabral CO; García-Roca P; Romero-Tejeda EM; Reyes H; Medeiros M; Castañeda-Hernández G; Trocóniz IF
    Br J Clin Pharmacol; 2015 Oct; 80(4):630-41. PubMed ID: 25846845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathophysiological idiosyncrasies and pharmacokinetic realities may interfere with tacrolimus dose titration in liver transplantation.
    Oteo I; Lukas JC; Leal N; Suarez E; Valdivieso A; Gastaca M; de Urbina JO; Calvo R
    Eur J Clin Pharmacol; 2011 Jul; 67(7):671-9. PubMed ID: 21327908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in paediatric liver transplant recipients.
    Kassir N; Labbé L; Delaloye JR; Mouksassi MS; Lapeyraque AL; Alvarez F; Lallier M; Beaunoyer M; Théorêt Y; Litalien C
    Br J Clin Pharmacol; 2014 Jun; 77(6):1051-63. PubMed ID: 24977292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of hematocrit on pharmacokinetics of tacrolimus in adult living donor liver transplant recipients.
    Minematsu T; Sugiyama E; Kusama M; Hori S; Yamada Y; Ohtani H; Sawada Y; Sato H; Takayama T; Sugawara Y; Makuuchi M; Iga T
    Transplant Proc; 2004 Jun; 36(5):1506-11. PubMed ID: 15251372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A New CYP3A5*3 and CYP3A4*22 Cluster Influencing Tacrolimus Target Concentrations: A Population Approach.
    Andreu F; Colom H; Elens L; van Gelder T; van Schaik RHN; Hesselink DA; Bestard O; Torras J; Cruzado JM; Grinyó JM; Lloberas N
    Clin Pharmacokinet; 2017 Aug; 56(8):963-975. PubMed ID: 28050888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.